Phase 2 trials

South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, is expected to invest up to 11 trillion won ($8.2 ...

With burgeoning demand for high-performance artificial intelligence chips, back-end process technology, which assembles various semiconductors and t...

South Korea’s artificial intelligence (AI) startup Upstage announced on Feb. 22 that it released the beta version of its open-source small lan...

South Korea’s central bank held its policy rate flat at 3.5% for a ninth straight session on Thursday as it was deemed too early for a rate cu...

Brookfield Asset Management Ltd. will increase its debt on the International Finance Center in Seoul (IFC Seoul), South Korea to up to 2.7 trillion ...

Samsung Electronics Co., the world’s largest memory chipmaker, has won its first 2-nanometer node artificial intelligence chip production cont...

Foreign investors bought more South Korean stocks and bonds in January, extending their buying spree to three months.The Financial Supervisory Servi...

Five activist funds have joined hands to wage a proxy battle with Samsung C&T Corp., demanding additional share buybacks and dividend increases....

Korea Exchange announced on Thursday that it will list Samsung Asset Management's "KODEX Global Obesity Treatment Top 2 Plus exchange-traded fund (E...

LG Energy Solution Ltd., the world’s second-largest rechargeable battery maker, drew a record 5.61 trillion won ($4.2 billion) in bids for a S...

South Korea's major defense system developer LIG Nex1 Co. has clinched a $3.2 billion deal to export its latest missile interceptor to Saudi Arabia,...

Kia Corp., South Korea’s second-largest automaker, has unveiled its next-generation military vehicle technologies at the largest defense exhib...

South Korea’s biopharmaceutical company Aprogen Inc. announced on Monday that its Phase 3 clinical trial for a biosimilar of Herceptin (trastu...

UBS Group AG and Citigroup Global Markets Inc. are set to manage the sale of a joint venture between global private equity giant KKR Co. Inc. and ai...

Hyundai Mobis Co., the world’s sixth-largest automotive parts maker, known as Mobis outside of its home South Korea, expects another strong ye...

South Korea’s Hyundai Mobis, the world’s sixth-largest auto parts maker, reported on Friday that its revenue was 59.25 trillion won ($44...

Mohegan Gaming & Entertainment (MGE) will open a foreigners-only casino at its resort complex in Incheon, South Korea in the first quarter after...

Global private equity firms, which recover their principal investment in South Korea, sell their assets for 2.5 times the purchase price on average,...

South Korea's Hanwha Ocean Co., the world's third-largest shipbuilder, announced on Monday that it has secured a contract for two very large ammonia...

South Korean electric vehicle and battery makers including Hyundai Motor Group and LG Energy Solution Ltd. have asked the US to ease requirements fo...

POSCO raised $5 million in three-year green bond sales on Jan. 16 to invest the proceeds in domestic facilities, the largest steelmaker in South Kor...

South Korea’s LG Chem Ltd. announced on Wednesday that its US-based subsidiary Aveo Pharmaceuticals will start Phase 3 clinical trials for its...

South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, saw the amount of listed local shares it owns rise...

South Korea's JW Pharmaceutical Corp., announced on Monday that it has received approval from the Malaysian National Pharmaceutical Regulatory Age...

The vast majority of creditors to Taeyoung Engineering & Construction Co. (Taeyoung E&C) have agreed to start debt restructuring for the tro...

The heirs of late Samsung Group Chairman Lee Kun-hee are seeking to sell their shares in Samsung Electronics Co. and other Samsung affiliates worth ...

POSCO International Corp. will step up global expansion in 2024 with a focus on electric vehicle components, eco-friendly energy exploration and gra...

LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...

South Korea's biotech company MedPacto Inc. announced on Tuesday that it has got approval from the US Food and Drug Administration (FDA) for its I...

South Korea's bio-regenerative medical firm CGBio announced on Tuesday that its Novosis Putty has been designated as a breakthrough device by the US...